Cytiva, a privately owned company founded in 1968 and headquartered in the United States, supplies products and services to the life sciences industry. Its portfolio includes several well-known brands, such as ÄKTA, Amersham, HyClone, MabSelect, and Whatman, which encompass a range of equipment and consumables used in various life science applications.
Cytiva provided a grant to the University of Hyderabad to support the establishment of its Alternative Protein Research Centre, which is now operational. In a separate development, Cytiva's ionizable lipid portfolio and pre-optimized lipid compositions demonstrated efficient in vivo delivery of CRISPR payloads. Niklas Jungnelius, a process modeling leader at Cytiva, noted the diversification of the therapeutic-antibody landscape at the BioProcess International Conference in Boston. A collaboration with WhiteLab Genomics will utilize AI-powered technology to optimize and accelerate stable cell line development through computer simulations. Materials used in experiments included hyaluronic acid, tryptone beef meal, nutrient agar, Cellufine Sulfate, UniGel-30CM, and melanoma B16F10 and HaCaT cells.
Subscribe for full access to Cytiva's products in full detail
Subscribe for full access to Cytiva's revenue in full detail
Subscribe for full access to Cytiva's products in full detail 
